Bevacizumab/ranibizumab/triamcinoloneEndophthalmitis following intravitreal administration: 19 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2012年 / 1419卷 / 1期

关键词：

Bevacizumab; Retinal Detachment; Triamcinolone; Ranibizumab; Macular Degeneration;

D O I：

10.2165/00128415-201214190-00046

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：12 / 12

相关论文

共 50 条

[1] Bevacizumab/ranibizumab/triamcinoloneEndophthalmitis: 21 case reports
Reactions Weekly, 2011, 1377 (1) : 11 - 11
[2] TriamcinoloneEndophthalmitis following intravitreal administration: case report
Reactions Weekly, 2010, 1322 (1) : 30 - 30
[3] TriamcinoloneEndophthalmitis following intravitreal administration: case report
Reactions Weekly, 2011, 1347 (1) : 38 - 38
[4] TriamcinoloneEndophthalmitis following intravitreal administration: case report
Reactions Weekly, 2009, 1252 (1) : 39 - 39
[5] Bevacizumab/ranibizumabFever (first report with ranibizumab) following intravitreal administration in elderly patients: 2 case reports
Reactions Weekly, 2010, 1300 (1) : 12 - 12
[6] Bevacizumab/triamcinoloneEndophthalmitis: 14 case reports
Reactions Weekly, 2023, 1960 (1) : 105 - 105
[7] Bevacizumab/ranibizumabOcular hypertension following intravitreal administration: 23 case reports
Reactions Weekly, 2012, 1414 (1) : 15 - 15
[8] Bevacizumab/ranibizumabIntraocular inflammation following intravitreal administration: 4 case reports
Reactions Weekly, 2010, 1330 (1) : 11 - 11
[9] Bevacizumab/ranibizumabSubretinal fibrosis following intravitreal administration: 7 case reports
Reactions Weekly, 2011, 1353 (1) : 8 - 8
[10] Pegaptanib/ranibizumab/triamcinoloneEndophthalmitis and uveitis: 11 case reports
Reactions Weekly, 2013, 1433 (1) : 33 - 33

← 1 2 3 4 5 →